Illumina, Inc. (NASDAQ: ILMN) today announced a sequencing agreement with the San Diego Zoo Wildlife Alliance (SDZWA)'s Frozen Zoo®. The 50-year-old biobank is the world's most comprehensive and ...

Monib Zirvi Ph.D. ’96 M.D. ’00 on Jan. 23 filed a petition asking the high court to review his malpractice claim alleging that Akin Gump, a prominent law firm who represented Cornell in litigation ...

For 50 years, scientists at the San Diego Zoo have been collecting and storing cells from rare and endangered species in its Frozen Zoo with an eye to the future. The future is here. The San Diego Zoo ...

Illumina, Inc. (NASDAQ:ILMN) Q4 2025 Earnings Call Transcript February 5, 2026 Illumina, Inc. beats earnings expectations. Reported EPS is $1.35, expectations were $1.26. Operator: Good day, ladies ...

Illumina, which specializes in DNA sequencing, will work on samples representing 1,300 species in the San Diego Zoo Wildlife Alliance's Frozen Zoo.

In early February 2026, Illumina reported past fourth-quarter 2025 revenue of US$1,159 million and net income of US$334 ...

Illumina Inc. (Nasdaq: ILMN), a genomics and molecular diagnostics company headquartered in San Diego, closed in late January on its acquisition of Boulder-based biotech firm SomaLogic Inc.

Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 5% year on year ...

Integration of HiFi Long-Read Whole-Genome Sequencing Expands the Collective Capabilities of iHope’s Global Rare Disease ...

Illumina Inc (ILMN) reports a 5% revenue increase and a 42% rise in non-GAAP EPS, while navigating uncertainties in research funding and expanding its multiomics portfolio.

PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the ...

Total company revenue is projected at “$4.5 billion to $4.6 billion, representing reported growth of 4% to 6%,” with operating margins expected at 23.3% to 23.5% in 2026. EPS guidance is “$5.05 to ...